This program consists of panel discussions and other sessions to gain knowledge on arrhythmia patients.
Search for "" returned 62 matches
This symposium will provide new developments in clinical strategies to treat arrhythmias.
Cryoballoon vs. RF Ablation: When to Use Each? (Activity Expired)21357
The EP on Point webinar series features 20 – 30 minute informative presentations from the experts.
This program is designed to provide electrophysiologists, cardiologists, cardiovascular surgeons, internists, and associated professionals with state-of-the-art information.
Review approaches to catheter ablation, cardiac arrhythmias, AF ablation, atrial tachycardias, atypical flutters, and ventricular arrhythmias with or without associated heart disease.
This symposium will give an overview of how catheter ablation has rapidly evolved over the years.
This meeting will be dedicated to pediatric arrhythmia management and focus on ventricular arrhythmias in children.
This symposium will have two educational sessions focusing on Interventional Therapies for Arrhythmias.
This activity is centered around heart rhythm management and implantable device management.
This case-based review will provide guidance and a sophisticated understanding of management techniques for patients that EP physicians are likely to encounter.
This conference will highlight understandings of basic mechanisms and new advances in clinical practice
WASHINGTON, DC — New multicenter research reveals that female patients fail ablation procedures more often than male patients, according to a study published in the February edition of the HeartRhythm Journal, the official journal of the Heat Rhythm Society. The study also shows that males undergo catheter ablation for the treatment of atrial fibrillation five times as often as females and typically with significantly fewer complications.
The International Winter Arrhythmia School is an excellent education program designed for professionals within the electrophysiology community, including physicians (electrophysiologists and cardiologists), trainees/fellows, and EP technicians/nurses.
2013 Women's Career and Leadership Development Conference for Women Cardiologists and Cardiothoracic Surgeons9147
The vision of the 2013 Women's Career and Leadership Development Conference for Women Cardiologists and Cardiothoracic Surgeons is to diversify the cardiology and cardiothoracic field by creating a vibrant community of women cardiologists and cardiothoracic surgeons that will strengthen their non-clinical professional skills, provide opportunities to enhance their professional standing, and encourage them to assume leadership positions in the field and within the American College of Cardiology.
The 12th International Dead Sea Symposium (IDSS): On Innovations in Cardiac Arrhythmias & Device Therapy12977
The Symposium will focus broadly on emerging technology and therapies to include all phases of the innovation process, (e.g., ongoing or recently completed studies on devices, ablation, and mapping). The program addresses hot topics on basic, pediatric and adult electrophysiology, including multidisciplinary approaches in treatment of AF, HF, and prevention of SCD. Courses on CRT, AF ablation and ECG workshop are included in the program. The program, abstracts and registration information are available on the Symposium website .
Symposium: Adopting Advanced Imaging Technology for Complex EP procedures
The meeting will present current and future management on sudden cardiac death, new drug and ablation treatment for atrial fibrillation, pacing and ICD advances, cardiac resynchronization techniques, remote patient monitoring, and advances in neuromodulation for heart failure and hypertension. The well received certificate Cardiac Rhythm Management Course will continue, and new courses on EPS/ECG added.
EP Live 2012
Application Advanced Mapping and Ablation Technologies (Activity Expired)15264
The session will explore the newer technologies that exist for mapping and ablating some of the common, and less common, substrates that may be treated in the pediatric and adult electrophysiology laboratory.
30 Years Of Ablation (Activity Expired)15265
This session is an historical journey through early DC ablation up to modern electroporative, automatic, and non-thermal ablation techniques, reviewed by a pioneer and expert in the field of interventional electrophysiology.
New Technologies for AF Ablation: Do They Add Value? (Activity Expired)15266
Emphasizing the limitations of current atrial mapping and ablation techniques and where improvement is needed.
This one-day, case-based format symposium is designed to update arrhythmia management health workers on relevant topics including, controversial issues, new and improved medications and devices, and new techniques for treating related conditions.
International Forum of Arrhythmia (IFA),Interventional Cardiology Mediterranean (IC-Med) ,Valve Summit (VS), Academy of Vascular and Endovascular Surgery (AVES), Congenital Heart Summit(CHS) will be the glittering parts of the scientific program.
The overall goal of the 4th Annual Duke EP Summitt is to enhance learners' knowledge and their ability to incorporate evidence-based updates in their practice.
EP and Device Therapy for Allied Professionals: Applying Knowledge to Clinical Practice
The 10th Winter Arrhythmia School is a collaboration between the Schulich Heart Program at University of Toronto, New York University, and Montreal Heart Institute. This year the educational program is divided into two streams: a devices stream and an electrophysiology stream, incorporated together for sessions of common interest. The combined sessions will be focused on innovations in device therapies, ablation approaches, as well as anti-arrhythmic and anti-thrombotic pharmacology.
This course is designed to provide the learner with the most up-to-date review of lead management and to give an in-depth review of indications for lead extraction and management of device infections as well as available tools and technology for extraction. A live extraction case will be featured, followed by a panel discussion by experts in the field.
Program faculty will review detailed illustrative cases with a step-by-step analysis, providing a current, in-depth review of approaches to catheter ablation for the spectrum of cardiac arrhythmias including atrial fibrillation, complex atrial arrhythmias after AF ablation or in congenital heart disease, atrial tachycardia’s and atypical flutters, and ventricular arrhythmias with or without associated heart disease.
HRS Patient Management Webinar - Riata Leads Experts Case Discussion (Activity Expired)8585
This 90-minute case-based, on demand webinar features leading electrophysiologists providing their clinical experience and personal views concerning patient managment options for cases involving Riata leads.
BOSTON, May 13, 2009 — Safe and effective management of patients with cardiovascular implantable devices (CIEDs) such as pacemakers and implantable cardioverter defibrillators (ICDs) is a complex and evolving issue. To ensure that physicians and facilities are adequately prepared to determine if and when lead extraction is necessary and to give patients the best possible care during these procedures, the Heart Rhythm Society has developed Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus Statement on Facilities, Training, Indications and Patient Management.The consensus statement was released today at Heart Rhythm 2009, the Society’s 30th Annual Scientific Sessions.
BOSTON, May 14, 2009 — Catheter ablation is now an important therapy option to be considered when trying to control recurrent ventricular tachycardias (VT). To ensure that physicians have up to date knowledge of this evolving therapy, which can be life-saving for some patients, and promote the best patient care, the European Heart Rhythm Association and the Heart Rhythm Society have prepared EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias. The consensus statement was released today at Heart Rhythm 2009, the Society’s 30th Annual Scientific Sessions.
Session 2: Transvenous Lead Surveillance and Indications for Lead Extraction (Activity Expired)13813
Enduring material that combines the pre-recorded cases and live questions and answer session of Session 2 of the clinical decision-making series.
This activity will review detailed illustrative cases regarding catheter ablation.
This activity will update medical practitioners on the future of cardiac electrophysiology and treatment guidelines on atrial fibrillation.
This case-based review will provide guidance and understanding of managing EP patients.
Advanced Ablation Course:Case Based Approach to Difficult Cardias Arrhythmias
WASHINGTON — The Heart Rhythm Society (HRS), written in joint partnership with European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS), issues an international consensus statement on indications, techniques and outcomes of catheter and surgical ablation of atrial fibrillation (AF).
This installment of the Clinical Decision-Making Seminar Series: Focus - Lead Management is presented in three segments, Pre-Recorded Cases, Live Questions and Answers, and Enduring Product.
John Hopkins Arrhythmia Symposium - A Case Based Approach
This is a one-day CME - accredited symposium being hosted for the first time at the MCW alumni center for cardiac electrophysiologist's.
The program will be comprised of interactive lectures complemented with panel discussions and case-based workshops designed to elicit a high degree of interaction between participants. Buffet breakfast and luncheon will be provided.
This meeting consists of four sections: AF Ablation, VT Ablation, Devices and New Technologies.
This course is designed to provide the learner with the most up to date evidence for ICD based therapy.
International Winter Arrhythmia School is an excellent program designed for the Electrophysiology Community, including Cardiologist, Trainees/Fellows, EP Technicians/Nurses and Family Physicians.
This course will provide full coverage of all the latest electrophysiological technologies and procedures through live cases performed by elite international operators and lectures by leading scientists.
EP live is a two day intensive educational meeting targeting practicing electrophysiologists as well as fellows in training.
A normal heartbeat is controlled by a smooth, constant flow of electricity through the heart. A short-circuit anywhere along this electrical pathway can disrupt the normal flow of signals, causing an arrhythmia (an irregular heartbeat). Cardiac ablation is a procedure used to destroy these short-circuits and restore normal rhythm, or to block damaged electrical pathways from sending faulty signals to the rest of the heart.
2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction30685
September 14, 2017—The 2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction, developed in collaboration with the ACC, AHA, APHRS, ASA, EHRA, IDSA, LAHRS, PACES, and STS, is intended to help clinicians in their decision-making process for managing leads and builds on the 2009 Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus on Facilities, Training, Indications, and Patient Management document. It provides practical clinical guidance in the broad field of lead management, including lead extraction.
|The document features a clinician summary (an educational derivative product of the full document) and a pocket card, developed in partnership with Guideline Central and available across multiple platforms, including print, electronic media, and the Guideline Central mobile app. Visit www.guidelinecentral.com to access the pocket card.|
March 9, 2017—Syncope has many causes and clinical presentations; the incidence depends on the population being evaluated. The purpose of this ACC/AHA/HRS guideline is to provide contemporary, accessible, and succinct guidance on the management of adult and pediatric patients with suspected syncope.
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation1285
|This document has been retired and replaced by "2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation."|
March 5, 2012—The purpose of the 2012 Consensus Statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of atrial fibrillation. It reports on the findings of a Task Force, convened by the Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA), and the European Cardiac Arrhythmia Society (ECAS) and charged with defining the indications, techniques, and outcomes of this procedure.
2018 EHRA Expert Consensus Statement on Lead Extraction: Recommendations on Definitions, Endpoints, Research Trial Design, and Data Collection Requ...32651
The Heart Rhythm Society endorsed the document on January 8, 2018.
March 16, 2018—This expert consensus statement provides recommendations for designing scientific studies, reports, and registries relating to lead extraction. The recommendations are directed to all scientists and health care professionals and are pertinent to clinical trials, registries, guidelines, quality assurance, and educational programs. The document also lists numerous gaps in evidence related to lead extraction, with the purpose to trigger joint collaboration in scientific trials and registries.
Arrhythmias in Congenital Heart Disease: A Position Paper of EHRA, AEPC, and ESC Working Group on Grown-up Congenital Heart Disease32704
The Heart Rhythm Society endorsed the document on October 5, 2017.
March 20, 2018—This position statement summarizes knowledge and provides recommendations on diagnosis and treatment of arrhythmias in patients with congenital heart defects (CHD), because, in many cases, the anatomy and management of arrhythmias in adult patients cannot directly be applied to patients with CHD. This document mainly addresses arrhythmias in adult CHD.
2003 Policy Statement on Catheter Ablation: Personnel, Policy, Procedures, and Therapeutic Recommendations1290
March 2003 — This Policy Statement provides updates about the rationale and indications for catheter ablative procedures and recommendations regarding electrophysiology laboratory personnel and facilities.
March 28, 2014 - A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society; developed in collaboration with the Society of Thoracic Surgeons. The goal of this guideline is to establish revised guidelines for optimum management of atrial fibrillation. This guideline supersedes the "2006 ACC/AHA/ESC Guideline for the Management of Patients with Atrial Fibrillation" and the two subsequent focused updates from 2011.
May 9, 2007 — Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS).
This document has been retired and replaced by "2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation."
May 14, 2009 — This Consensus Statement provides a state-of-the-art review on catheter ablation of ventricular tachycardia (VT). It reports on the findings of a Task Force representing the European Heart Rhythm Association (EHRA) and the Heart Rhythm Society (HRS) charged with defining the indications, techniques, and outcomes of this procedure.
June 1, 2016 - This consensus statement provides up-to-date clinical practice guidelines for the use of catheter ablation in children 0–18 years of age with any arrhythmia, and in all patients with congenital heart disease.
May 13, 2015 - The 2015 HRS Document on POTS/IST/VVS was released during the 2015 HRS Scientific Sessions. The document will be published in the 2015 June Edition of the HeartRhythm Journal.
September 23, 2015 - Since 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific evidence into clinical practice guidelines with recommendations to improve cardiovascular health.
December 10, 2015 - The evolution of LAA occlusion technology has spanned nearly two decades and three FDA panel hearings, leading to FDA approval in 2015. As this technology becomes clinically available to a broader population of patients, it is essential that physician stakeholders establish criteria for the performance of these procedures that will be used in granting initial and ongoing privileges. These criteria are offered to support The Joint Commission mandate that medical staff privileges be granted on the basis of professional criteria specified in the medical staff bylaws to ensure safe and effective patient-centered care.
Cardioversion is a corrective procedure where an electrical shock is delivered to the heart to convert, or change, an abnormal heart rhythm back to normal sinus rhythm. Most elective or "non-emergency" cardioversions are performed to treat atrial fibrillation (A Fib) or atrial flutter (AFL), non-life threatening abnormal heart rhythms. Cardioversion is used in emergency situations to correct an abnormal rhythm when it is accompanied by faintness, low blood pressure, chest pain, difficulty breathing, or loss of consciousness.
2002 NASPE Expert Consensus Conference: Radiofrequency Catheter Ablation in Children with and without Congenital Heart Disease1292
June 2002—Based on the Consensus Conference held during the 21st Annual Scientific Sessions of the North American Society of Pacing and Electrophysiology (NASPE; now known as the Heart Rhythm Society), this consensus statement covers issues of specific cardiac arrhythmias in children with or without congenital heart disease (CHD), the special needs of children and patients with CHD, and how best to meet these needs.
|This document has been retired and replaced by 2016 “PACES/HRS Expert Consensus Statement on the Use of Catheter Ablation in Children and Patients with Congenital Heart Disease.”|